PETQ logo

PetIQ (PETQ) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

21 July 2017

Indexes:

Not included

Description:

PetIQ, Inc. produces medicines for pets. The company offers prescription drugs for pets, including treatments for arthritis, thyroid gland, diabetes, pain relief, as well as medications for heartworm prevention, antibiotics, and other specialty drugs, as well as over-the-counter medications and accessories, such as flea and tick control products in various forms, including spot treatments, chewable tablets, and collars. It also provides wellness services and wellness products, which include dental procedures and dietary supplements. The company was founded in 2010 and its headquarters is located in Eagle, Idaho.

Key Details

Price

$30.98

Annual Revenue

$1.10 B(+19.58% YoY)

Annual EPS

$0.07(+104.24% YoY)

PE Ratio

79.44(+83.93% YoY)

Beta

0.34

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

08 Aug '24 Truist Securities
Hold
10 May '24 Benchmark
Buy
19 Mar '24 Jefferies
Buy
19 Dec '23 Jefferies
Buy
02 Oct '23 Truist Securities
Buy
06 Sept '23 Lake Street
Buy
15 Aug '23 Benchmark
Buy
13 Feb '23 Benchmark
Buy
25 Oct '22 Raymond James
Outperform
10 Aug '22 Raymond James
Outperform

Screeners with PETQ included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group
PETQ
globenewswire.com25 October 2024

EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion.

PetIQ, Inc. Announces Results of Special Meeting of Stockholders
PetIQ, Inc. Announces Results of Special Meeting of Stockholders
PetIQ, Inc. Announces Results of Special Meeting of Stockholders
PETQ
globenewswire.com22 October 2024

Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS
PETQ
accesswire.com09 October 2024

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
PETQ
accesswire.com07 October 2024

NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

PetIQ (PETQ) Upgraded to Strong Buy: What Does It Mean for the Stock?
PetIQ (PETQ) Upgraded to Strong Buy: What Does It Mean for the Stock?
PetIQ (PETQ) Upgraded to Strong Buy: What Does It Mean for the Stock?
PETQ
zacks.com13 September 2024

PetIQ (PETQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PETQ Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PetIQ, Inc. Is Fair to Shareholders
PETQ Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PetIQ, Inc. Is Fair to Shareholders
PETQ Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PetIQ, Inc. Is Fair to Shareholders
PETQ
businesswire.com07 September 2024

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PetIQ, Inc. (NASDAQ: PETQ) to Bansk Group for $31.00 per share in cash is fair to PetIQ shareholders. Halper Sadeh encourages PetIQ shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether PetIQ and its board of directo.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. - PETQ
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. - PETQ
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. - PETQ
PETQ
prnewswire.com09 August 2024

NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ
PETQ
accesswire.com08 August 2024

NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of PetIQ, Inc. – PETQ
PETQ
globenewswire.com07 August 2024

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating PetIQ, Inc . ( Nasdaq : PETQ ) , relating to its proposed merger with Bansk Group. Under the terms of the agreement, PetIQ shares will be automatically converted into the right to receive $31.00 in cash per share.

Shareholder Alert: Ademi LLP investigates whether PetIQ, Inc. has obtained a Fair Price for its Public Shareholders
Shareholder Alert: Ademi LLP investigates whether PetIQ, Inc. has obtained a Fair Price for its Public Shareholders
Shareholder Alert: Ademi LLP investigates whether PetIQ, Inc. has obtained a Fair Price for its Public Shareholders
PETQ
prnewswire.com07 August 2024

MILWAUKEE, Aug. 7, 2024 /PRNewswire/ -- Ademi LLP is investigating PetIQ (Nasdaq: PETQ) for possible breaches of fiduciary duty and other violations of law in its transaction with Bansk. Click here to learn how to join our investigation https://www.ademilaw.com/case/petiq-inc or call Guri Ademi toll-free at 866-264-3995.

FAQ

  • What is the primary business of PetIQ?
  • What is the ticker symbol for PetIQ?
  • Does PetIQ pay dividends?
  • What sector is PetIQ in?
  • What industry is PetIQ in?
  • What country is PetIQ based in?
  • When did PetIQ go public?
  • Is PetIQ in the S&P 500?
  • Is PetIQ in the NASDAQ 100?
  • Is PetIQ in the Dow Jones?
  • When was PetIQ's last earnings report?
  • When does PetIQ report earnings?
  • Should I buy PetIQ stock now?

What is the primary business of PetIQ?

PetIQ, Inc. produces medicines for pets. The company offers prescription drugs for pets, including treatments for arthritis, thyroid gland, diabetes, pain relief, as well as medications for heartworm prevention, antibiotics, and other specialty drugs, as well as over-the-counter medications and accessories, such as flea and tick control products in various forms, including spot treatments, chewable tablets, and collars. It also provides wellness services and wellness products, which include dental procedures and dietary supplements. The company was founded in 2010 and its headquarters is located in Eagle, Idaho.

What is the ticker symbol for PetIQ?

The ticker symbol for PetIQ is NASDAQ:PETQ

Does PetIQ pay dividends?

No, PetIQ does not pay dividends

What sector is PetIQ in?

PetIQ is in the Healthcare sector

What industry is PetIQ in?

What country is PetIQ based in?

PetIQ is headquartered in United States

When did PetIQ go public?

PetIQ's initial public offering (IPO) was on 21 July 2017

Is PetIQ in the S&P 500?

No, PetIQ is not included in the S&P 500 index

Is PetIQ in the NASDAQ 100?

No, PetIQ is not included in the NASDAQ 100 index

Is PetIQ in the Dow Jones?

No, PetIQ is not included in the Dow Jones index

When was PetIQ's last earnings report?

PetIQ's most recent earnings report was on 7 November 2024

When does PetIQ report earnings?

The date for PetIQ's next earnings report has not been announced yet

Should I buy PetIQ stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions